CAS 126882-53-9: b-D-Xylopyranoside,(2S,3S)-4-hydroxy-2,3-bis[(4-hydroxy-3,5-dimethoxyphenyl)methyl]butyl (9CI)

Ssioriside shows moderate antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical.

Ssioriside is a synthetic compound that represents a novel class of biochemical agents, which is primarily derived from advanced chemical synthesis techniques designed to replicate active biochemical moieties found in several naturally occurring substances. Its mode of action involves the modulation of specific molecular pathways, potentially altering enzyme activity or receptor interactions, thereby influencing cellular processes at a fundamental level. The uses and applications of Ssioriside are primarily in the realm of experimental pharmacology and chemical biology, where it serves as a tool for probing biological systems or as a lead compound in the development of new therapeutic agents. Researchers utilize it to explore its effects on cellular mechanisms, potentially leading to insights that could inform drug development, particularly in fields where modulation of its target pathways shows therapeutic promise. While still under investigation, Ssioriside's potential roles in disease models highlight its significance as a subject of ongoing scientific inquiry.